AI Scribe Use Modestly Reduces Clinical Documentation Time
Medically reviewed by Drugs.com
via HealthDayTHURSDAY, April 9, 2026 -- Adoption of artificial intelligence (AI) scribes is linked to modest reductions in electronic health record (EHR) use and clinical documentation time, according to a study published online April 1 in the Journal of the American Medical Association.
Lisa S. Rotenstein, M.D., from the University of California, San Francisco, and colleagues examined the association between AI scribe adoption and changes in EHR time expenditure and visit volume. The analysis included 8,581 ambulatory clinicians from five U.S. academic health care institutions.
The researchers found that 21 percent of clinicians were AI scribe adopters, with AI scribe adoption associated with 13.4 fewer minutes of EHR time, 16.0 fewer minutes of documentation time, and 0.49 additional weekly visits delivered. There was no significant change in EHR time outside work hours. Primary care providers experienced the greatest changes associated with AI scribe adoption, as did advanced practice clinicians, female clinicians, and clinicians who used AI scribes in ≥50 percent of visits.
"The modest reductions in documentation time we observed are unlikely to fully account for changes in burnout, underscoring the need to understand how these tools change how clinicians approach care delivery while using them," senior author Rebecca G. Mishuris, M.D., from Mass General Brigham in Somerville, Massachusetts, said in a statement.
Several authors disclosed ties to industry.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-10 01:59
Read more
- Listening to Music for 24 Minutes May Ease Anxiety, Study Finds
- New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
- FDA Approves Foundayo (orforglipron), the Only GLP-1 Pill for Weight Loss That Can be Taken Any Time of Day Without Food or Water Restrictions
- America's Sexual Health Report Card Contains Some Surprises
- Prenatal Valproate Exposure Tied to Offspring Neurodevelopmental Risks
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions